Intelligence Ventures invested $25K in Aperture Bio as part of IV Accelerator Cohort I. Aperture Bio is a spatial biology platform that predicts oncology drug candidate efficacy using 3D tumor models and AI.
Aperture Bio captures disease state biosignatures used to develop personalized cancer therapies via our transformative 3D biology platform
Aperture Bio captures disease state biosignatures used to develop personalized cancer therapies via our transformative 3D biology platform.